Dr. Nagourney's Blog


Informative articles sent right to your inbox. Subscribe to Dr. Nagourney's blog today.

The Cost of Care for Stage 4 Colon Cancer: How Much is Too Much?
By Robert A. Nagourney, MD
Among the most important topics of discussion at cancer meetings today is the cost of cancer care. Terms like “financial toxicity” are used to describe the growing out-of-pocket and institutional expenses associated with the use of advanced...
Chemosensitivity Testing – What It Is and What It Isn’t
By Robert A. Nagourney, MD
Several weeks ago I was consulted by a young man regarding the management of his heavily pre-treated, widely metastatic rectal...
Bevacizumab In Colon Cancer – “A Shot Across The Bowel”
By Robert A. Nagourney, MD
An E-Publication article in the February Journal of Clinical Oncology analyzes the cost efficacy of Bevacizumab for colon...
Toward A 100% Response Rate in Human Cancer
By Robert A. Nagourney, MD
Oncologists confront numerous hurdles as they attempt to apply the new cancer prognostic and predictive tests. Among them are...
Every Cancer Patient Outcome is Important - Stage 4 Stomach Cancer
By Robert A. Nagourney, MD
Clinical oncologists can be divided into different camps. There are those who see patient outcomes as a means-to-an-end. Each...
Cancer Patients Who Get Better, Get Better - Metastatic Colon Cancer
By Robert A. Nagourney, MD
A study published in the October 20 Journal of Clinical Oncology (Use of early tumor shrinkage to predict long-term outcome in...
Cancer Medicine – A Humbling Experience
By Robert A. Nagourney, MD
In his brilliant 1998 book, Consilience, Edward O. Wilson, notes: “The cost of scientific advance is the humbling recognition...

most popular articles

patient story

How We Helped David Hanbidge

"I'll never forget the day when the doctor took my wife and me to a small back office and told us the horrible news…I had the very worst kind of lung cancer..."   Read about how we helped David.